Ocugen, Inc. (OCGN)
1.43
+0.02
(+1.42%)
USD |
NASDAQ |
Feb 13, 14:13
Ocugen Free Cash Flow : -53.53M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CorMedix, Inc. | 74.42M |
| Belite Bio, Inc. | -- |
| Verastem, Inc. | -140.93M |
| Anavex Life Sciences Corp. | -34.08M |
| AnaptysBio, Inc. | -145.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.92M |
| Cash from Investing (Quarterly) | -0.086M |
| Cash from Financing (Quarterly) | 18.51M |
| Free Cash Flow Per Share (Quarterly) | -0.0428 |
| Free Cash Flow to Equity (Quarterly) | -13.15M |
| Free Cash Flow to Firm (Quarterly) | -11.69M |
| Free Cash Flow Yield | -12.70% |